Navigation Links
Malaysian Mountain Climbing Icon Ravi Everest Joins 9th Annual Expedition Mt. Kinabalu to Raise Awareness for Duchenne Muscular Dystrophy
Date:7/19/2019

World renowned two-time Everest summiter Ravichandran Tharumalingam, who is also known as “Ravi Everest,” will be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in Sabah, Malaysia, to be held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy and was founded by Sabahan Catherine Jayasuriya.

Jayasuriya, who lives in California, grew up in Kota Kinabalu and always dreamed of taking her children to the summit of its sentinel mountain. Her son, Dusty Brandom, has Duchenne and would never make the climb. At 26, Dusty is in a wheelchair and severely impacted by the muscle wasting disease. He travelled to Sabah in 2011 to visit his grandfather Tan Sri Thomas Jayasuriya but is now too physically impacted to make the long journey.

“Their bodies fail them but their mind and dreams are strong,” said Jayasuriya. “Dusty is my daily inspiration and he inspires everyone he knows as he overcomes personal adversity with a smile on his face. I climb for him.”

Dusty and the challenges faced by boys and young men with Duchenne have inspired Ravi Everest to become involved with the cause. His global ambitions match Coalition Duchenne’s goal of raising global awareness about Duchenne. Ravi Everest has climbed mountains all over the world proudly flying the Malaysian flag. He is currently working on the “Seven Summits Challenge,” which is a quest to climb the highest mountains on each continent, as well as the “Eight Thousander” challenge of climbing all 14 mountains over 8,000 meters. To top it all he is committed to achieving the “Grand Slam,” which adds the North Pole and the South Pole to the Seven Summits.

Ravi Everest has successfully conquered Mt. Everest twice, once in 2006 and again in 2007. Throughout his climbs he has endured many challenges, such as near-death in an avalanche on Mt. Manaslu, in Nepal in 2012, and losing eight fingers to frostbite on Everest in 2006. Despite these challenges, he continues to push himself to climb the most challenging mountains and inspire others. As a motivational speaker, Ravi wishes to inspire everyone to achieve the summit of their dreams.

Jayasuriya believes strongly in acting locally but thinking globally. She is an advocate for Malaysian patients to have access to drugs for Duchenne currently being developed in the US and Europe.

“Boys and young men with Duchenne in this region need a voice and access to new drugs,” said Catherine.

Validating Jayasuriya’s advocacy, a pioneering Duchenne clinical trial is recruiting patients at two sites in Malaysia. PTC Therapeutics, a US-based biopharmaceutical company, is the sponsor of the clinical trial. Investigators are looking for boys with Duchenne aged five and above who still have the ability to walk. The study examines whether the PTC drug ataluren can delay Duchenne progression and maintain patients’ ability to walk, run, and climb up and down stairs over a period of 144 weeks. The safety of ataluren is also being assessed.

The Principal Investigators at the two clinical trial sites in Malaysia are Teik Beng Khoo, MD at Kuala Lumpur Hospital, and Meow Keong Thong, MD at University Malaya Medical Centre.

It is hoped that the results of this trial will drive better understanding of Duchenne and its treatment, and ultimately benefit future patients.

Dusty and his 93-year-old grandfather, Tan Sri Thomas Jayasuriya, are featured in Catherine Jayasuriya’s award-winning film Dusty’s Trail: Summit of Borneo. The film is the story of Dusty’s journey with Duchenne, and it tells about people coming together from around the world to climb Mt. Kinabalu to raise awareness. Dusty’s Trail has an important message of hope in the face of adversity, and shows the beauty of Sabah and its people to the world.

“I’m inspired by the determination of boys and young men with Duchenne like Dusty,” said Ravi Everest.

Read the full story at https://www.prweb.com/releases/malaysian_mountain_climbing_icon_ravi_everest_joins_9th_annual_expedition_mt_kinabalu_to_raise_awareness_for_duchenne_muscular_dystrophy/prweb16449440.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. 2013 Bio Convention Provides Springboard For Malaysian Biotech
2. Rocky Mountain Biologicals Expands Custom Serum Filtration Facility
3. White Mountain Process Announces Sanitary Autoclave Style Pharmaceutical Agitator
4. Newborn Calf Serum Added to Growing Product Suite of Rocky Mountain Biologicals
5. Rocky Mountain Biologicals Joins International Serum Industry Association
6. Medical Manufacturing to Mountaineering: KMC Employees Take it to the Top
7. San Antonio Investigators Report on Mountain Cedar Allergy Model
8. White Mountain Process' New Whisper Technology Creates World's Only Squeal-less Mechanical Seal
9. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
10. EnduRx Pharmaceuticals to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
11. Rocky Mountain Biologicals CEO Selected to Participate in the 2013 Montana Economic Development Conference in Butte
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO World Congress ... Growers Association (NCGA) announced the winners of the Consider Corn Challenge II. Three ... using field corn to produce biobased materials. , “Corn is a sustainable, abundant ...
(Date:7/2/2019)... (PRWEB) , ... July 02, 2019 , ... Leading Regenerative ... entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on regenerative veterinary ... animals. Animal Pharm was recently included in the Brentwood and Pacific ...
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, Inc. (NASDAQ: ... for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for IVERIC bio’s ... pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal diseases. IVERIC ...
(Date:6/12/2019)... N.J. (PRWEB) , ... June 12, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and ... Shanghai Zillion has been signed. The agreement will grant exclusive rights for Zillion ...
Breaking Biology Technology:
(Date:8/14/2019)... TORONTO (PRWEB) , ... August 13, 2019 , ... ... Cancer Medicine Team, Division of Molecular Pathology, Institute of Cancer Research (ICR) in ... (5pm BST/UK) to learn about the process of biomarker and companion diagnostic development ...
(Date:8/6/2019)... ... August 06, 2019 , ... ... manufacturing with clinical, regulatory and GMP manufacturing experience. In November it spun ... With extensive regulatory experience and one of the first cGMP cell ...
(Date:8/4/2019)... ... August 02, 2019 , ... Stay on top of current ... and food industries. Access to all webinars is free, so be sure to register ... field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS ...
Breaking Biology News(10 mins):